Effects on re-endothelialisation with Bydureon treatment add on to Insulin versus Insulin alone, both in combination with Metformin in type 2 diabetic subjects (Rebuild Study).
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2017
At a glance
- Drugs Exenatide (Primary) ; Exenatide (Primary) ; Insulin aspart; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Rebuild
- 30 Nov 2017 Planned End Date changed from 1 Apr 2019 to 1 Dec 2019.
- 30 Nov 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 10 Jun 2017 Biomarkers information updated